TOLANITY Trademark

Trademark Overview

On Monday, August 8, 2016, a trademark application was filed for TOLANITY with the United States Patent and Trademark Office. The USPTO has given the TOLANITY trademark a serial number of 87130395. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 9, 2020. This trademark is owned by Pfizer Inc.. The TOLANITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
tolanity

General Information

Serial Number87130395
Word MarkTOLANITY
Filing DateMonday, August 8, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Thursday, March 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 9, 2020ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019EXTENSION 5 GRANTED
Thursday, July 25, 2019EXTENSION 5 FILED
Tuesday, July 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Thursday, January 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 8, 2019EXTENSION 4 GRANTED
Tuesday, January 8, 2019EXTENSION 4 FILED
Tuesday, January 8, 2019TEAS EXTENSION RECEIVED
Wednesday, July 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 16, 2018EXTENSION 3 GRANTED
Monday, July 16, 2018EXTENSION 3 FILED
Monday, July 16, 2018TEAS EXTENSION RECEIVED
Thursday, January 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2018EXTENSION 2 GRANTED
Tuesday, January 16, 2018EXTENSION 2 FILED
Tuesday, January 16, 2018TEAS EXTENSION RECEIVED
Wednesday, July 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 17, 2017EXTENSION 1 GRANTED
Monday, July 17, 2017EXTENSION 1 FILED
Monday, July 17, 2017TEAS EXTENSION RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 31, 2016ASSIGNED TO EXAMINER
Thursday, August 11, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 11, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

tolanity preparations pharmaceutical treatment human vaccines dysfunction allergies erectile disorders viral